ETV5 and endometrial cancer: Up-regulated in endometrial cancer by the inducer of myometrial infiltration ERM/ETV5 [55]; Protective role against oxidative-stress induced apoptosis in endometrial cancer [55]; Down-regulated in ovarian tumors following cisplatin treatment [32]